^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    satricabtagene autoleucel (CT041)

    i
    Other names: CT041, CAR-CLD18 T Cell Therapy, Claudin18.2-redirected Autologous Cells, Humanized CAR-CLD18 T Cell Therapy, Claudin 18.2-CAR-T cell therapy
    Company:
    CARsgen, Changhai Hospital
    Drug class:
    CLDN18.2-targeted CAR-T immunotherapy
    Related drugs: